EDAP TMS leading position in HIFU for Prostate Cancer and ESWL for Urinary Stones

EDAP TMS is a pioneer and a market leader in Extracorporeal ShockWave Lithotripsy (ESWL) with the Sonolith^® range of devices. With Ablatherm^® HIFU and its recently introduced Focal One^®, EDAP TMS is the the leader in High Intensity Focused Ultrasound (HIFU) for the treatment of Prostate Cancer. Both technologies are based on ultrasound waves but their markets and contexts are distinct, and they therefore require specific marketing strategies.

The Company's business strategy is to capitalize on its expertise in therapeutic ultrasound and its position in urology to achieve long-term growth as a leader in the development, production, marketing and distribution of minimally-invasive medical devices for urological and other indications, primarily using HIFU and shock wave technologies.